35
Participants
Start Date
April 15, 2024
Primary Completion Date
October 17, 2025
Study Completion Date
October 17, 2025
Fetal Oxygenation Measurements
The Lumerah device, and Oxiplex ISS will be positioned on the maternal abdomen in various locations depending on the sonographic evaluation. The transvaginal sensor will be placed after rupture of the maternal membranes and appropriate descent of the fetus.This study is for data collection purposes only. Neonates of this study arm will also be monitored with the Oxiplex ISS system. This study is for data collection purposes only.
Sentara Norfolk General - Eastern Virginia Medical School, Norfolk
National Institutes of Health (NIH)
NIH
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Raydiant Oximetry, Inc.
INDUSTRY